ASML's EUV R&D is starting to pay off through operating leverage. Q3 R&D fell as a share of sales, though one quarter is not a trend. Higher units, IBM sales and EUV/DUV prices put 2028 estimates well above the 2030 guide and ahead of consensus; shares look cheap at €1,530. Assuming 30% prepayment, liabilities imply €42-45bn of orders in 2026's first nine months, subject to invoicing lags. The proposed MATCH Act could restrict China sales; 2029-30 demand is less certain than 2028. x.com  x.com  … Show more

ASML's planned 2027-28 output cannot meet customer demand, supporting a Buy rating and €1,830 target. Long-term customer down payments rose from €3.6bn to €9.3bn; customers seek 2029-30 orders that ASML has not accepted. Critical-tool price rises begin in 2027, with full effect in 2028, but are not meant to recur annually. Q3 EPS excluding a €509.7m investment gain still beat consensus. x.com  x.com  x.com  x.com  x.com 

ASML faces moat erosion now that China has a homegrown alternative to its machines. The Information reports a state-backed Shanghai company has started mass-producing DUV lithography tools. Chinese fabs stockpiling older DUV tools had become a major revenue driver, with China at 36% of sales in 2024 and 29% last year. Output is tiny, about five machines this year and maybe twenty next. But once a second supplier exists, the question shifts from "no alternative" to "for how long." x.com 

ASML is getting paid more for each tool, moving beyond proving it can build enough of them. Q3 2026 brings pricing power and an order book reaching 2030; the house view has strengthened, with high conviction. x.com 

ASML's sharp profit growth supports its $2,100 stock valuation. Stock Analysis reports quarterly profit rose from €2.0 billion a year earlier to €4.8 billion. The new call is below the earlier $3,000 valuation based on ASML's EUV lithography monopoly. x.com 

ASML may have topped, since semicap thrives on shortage and would be hit hardest in an overbuild. Then earnings acceleration from memory and fab projects stops or reverses; the labs' leading-edge chase may be at its apex, positioning is bullish and the moat is threatened. Bullishness on Korean, US and Taiwan fab projects makes sense for now. But if the cycle top is confirmed and labs change how they chase the frontier, or token deflation kills some labs, the shortage can end sooner. x.com  x.com  … Show more

ASML's EUV moat is hard to replicate because making EUV light is only one part of a production tool: sustained fab uptime matters, and Zeiss optics are the harder moat. Langdao Silex showed a Chinese light source with 90% local components but disclosed no power figure. ASML's production sources run at about 600W; its February demo reached 1,000W with a path to 1,500W. Langdao staff put mass production three to five years away. x.com 

ASML's growing installed base generates recurring service revenue that raises its revenue floor during industry downturns. Fiscal.ai's chart shows quarterly service and field option revenue of 3,289 million in September 2026. ASML's CEO says planned supply for 2027 and 2028 will not fully meet customer demand, and the company is exploring capacity beyond the previously communicated 30% increase for 2028. x.com  x.com 

ASML's valuation does not make sense at 45-50x forward earnings unless estimates are too low by around 2x. It has always had pricing power but chosen not to exercise it; that may change, but if it does not, the multiple is hard to justify relative to other opportunities. x.com  x.com 

ASML's earnings beat and higher 2026 guidance suggest its run is not stopping anytime soon. EPS of €12.95 exceeded the €10.60 estimate, and full-year guidance was raised to €44-45B. x.com